Compare AEHR & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AEHR | SPRY |
|---|---|---|
| Founded | 1977 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 858.8M | 833.1M |
| IPO Year | 1997 | 2020 |
| Metric | AEHR | SPRY |
|---|---|---|
| Price | $70.30 | $8.07 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $29.50 | ★ $40.00 |
| AVG Volume (30 Days) | ★ 3.0M | 1.5M |
| Earning Date | 04-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $58,968,000.00 | ★ $84,278,000.00 |
| Revenue This Year | N/A | $90.76 |
| Revenue Next Year | $72.01 | $81.70 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.72 | $6.66 |
| 52 Week High | $74.53 | $18.63 |
| Indicator | AEHR | SPRY |
|---|---|---|
| Relative Strength Index (RSI) | 76.83 | 43.77 |
| Support Level | $19.19 | $7.20 |
| Resistance Level | N/A | $8.70 |
| Average True Range (ATR) | 5.62 | 0.49 |
| MACD | 3.62 | 0.05 |
| Stochastic Oscillator | 91.49 | 56.49 |
Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.